Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Activist Carl Icahn Gets Two Representatives on Hologic, Inc. (HOLX)’s Board

Billionaire Carl Icahn‘s activist position in Hologic, Inc. (NASDAQ:HOLX) takes a new step with the nomination of two representatives on the company’s board of directors. According to a press release attached to a filing with the Securities and Exchange Commission, Jonathan Christodoro and Samuel Merksamer have been appointed to Hologic’s board.


Following the nominations, the board of the company has expanded to 11 directors, 10 of whom are independent.

“Hologic is a leader in women’s health with innovative, market-leading technologies, and the Company is well-positioned to take advantage of multiple opportunities, […] As members of the Board, Jonathan and Sam will work with the other directors and the management team to enhance the value of the Company for all shareholders. Our record shows that our involvement on boards has often created meaningful value for all shareholders. We hope this will continue with Hologic,” Carl Icahn said in the statement.

Hologic, Inc. (NASDAQ:HOLX) also reported today that Dr. Burton Drayer has been engaged a scientific advisor to the company.

“Given his experience and deep knowledge in medical diagnostics and radiology, I believe that Dr. Drayer will be an extremely valuable resource to the Company going forward,” Mr. Icahn also said.

The billionaire initiated a big activist position in Hologic in November, disclosing a 12.63% stake, which contains 34.2 million shares. Amid the move made by Icahn Hologic, Inc. (NASDAQ:HOLX) had to adopt a stockholder rights plan to prevent a possibility of a hostile takeover.

Also on Monday, Hologic, Inc. (NASDAQ:HOLX) announced that it has named Stephen P. MacMillan as the new President and CEO of the company.

At the end of September, several big hedge funds owned shares of Hologic, Inc. (NASDAQ:HOLX), the latest round of 13F filings revealed. One of them is Levin Capital Strategies, managed by John A. Levin, which owns some 4.6 million shares, worth $94.4 million. Barry Rosenstein’s Jana Partners revealed holding 3.6 million shares, worth $73.5 million, among others.

Last week, Mr. Icahn disclosed that he has entered into an agreement with another energy company, Talisman Energy Inc. (USA) (NYSE:TLM), following which, also Mr. Christodoro and Mr. Merksamer have been nominated to the company’s board of directors. Mr. Icahn holds 7.37% of the Talisman’s common stock, increasing the holding to 76.1 million shares, from 71.8 million owned earlier.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!